NEW YORK, Aug. 13, 2026, 08:20 EDT
Madison Square Garden Sports Corp. NYSE:MSGS climbed 3.35% to $427.99 before Thursday’s opening bell. That followed Wednesday’s 5.25% record-close gain. Together, the moves add about 8.8%.
The catalyst was unusually clear. Josh Kushner and former Disney chief Bob Iger agreed to buy the Los Angeles Lakers for $12.5 billion. The price is 25% above the team’s $10 billion valuation only 14 months earlier.
The news also pushed “josh kushner” above 500,000 U.S. searches. It was an active Google trend early Thursday. For MSGS investors, the useful signal is the transaction price, not the search volume. Google Trends
| Franchise or reference | Value | Status | Investor read-through |
|---|---|---|---|
| Los Angeles Lakers | $10.00 billion | 2025 transaction value | Prior benchmark |
| Los Angeles Lakers | $12.50 billion | 2026 pending deal | 25% increase in 14 months |
| New York Knicks | $9.85 billion | Sportico estimate cited by Bloomberg | MSGS basketball asset |
| New York Rangers | $3.65 billion | Sportico estimate cited by Bloomberg | MSGS hockey asset |
Those third-party estimates value the Knicks and Rangers at $13.5 billion combined. MSGS reported $164.5 million of cash and $258.5 million of debt at June 30. Subtracting that $94 million net debt leaves a preliminary equity reference near $13.41 billion.
Google Finance showed a $9.47 billion market value at Wednesday’s close. Scaling that figure by the premarket move gives roughly $9.79 billion. The gap to the adjusted franchise reference is therefore about $3.6 billion, or 27%. This is a preliminary calculation.
The gap is not simply a trading anomaly. Team appraisals are estimates, while MSGS shares carry public-market liquidity, governance and tax considerations. Still, a $12.5 billion Lakers deal gives investors a new cash-market benchmark.
Fresh results added operating evidence Thursday. Fiscal fourth-quarter revenue rose 37% to $278.7 million. Operating income reached $32.2 million, reversing a $22.6 million loss. The Knicks’ championship run drove $66.9 million of additional playoff revenue.
| Metric | Fiscal Q4 2026 | Year-over-year change | Fiscal 2026 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $278.7 million | +37% | $1.154 billion | +11% |
| Operating income | $32.2 million | From a $22.6 million loss | $28.9 million | +95% |
| Adjusted operating income | $39.6 million | From a $16.8 million loss | $58.7 million | +54% |
| Cash from operations | — | — | $62.7 million | -32% |
Cash conversion was less impressive. Full-year operating cash flow fell by $28.9 million to $62.7 million. That decline tempers the headline profit growth and keeps the investment case tied to scarce-asset value.
Executive Chairman James Dolan said the year featured “robust demand” across the business. He added that MSGS was making progress on its proposed Rangers separation. The company now expects that spin-off by the end of October, subject to final conditions and board approval. MSG Sports
The split matters because it could give each team a visible standalone price. It does not force a sale. Dolan family control remains intact, and the market may preserve a holding-company discount after separation.
| Analyst | Firm | Rating | Target | Upside/downside vs. $427.99 |
|---|---|---|---|---|
| Curry Baker | Guggenheim | Buy | $522 | +22.0% |
| David Karnovsky | J.P. Morgan | Buy | $450 | +5.1% |
| Cameron Mansson-Perrone | Morgan Stanley | Buy | $450 | +5.1% |
| Joseph Stauff | Susquehanna | Buy | $430 | +0.5% |
| David Joyce | Seaport Global | Buy | $435 | +1.6% |
| Jason Bazinet | Citi | Hold | $360 | -15.9% |
Five of seven analysts tracked by Google Finance rate MSGS a buy. Two say hold, and none say sell. Their average target is $441.17, only 3.1% above the premarket price. The rally has compressed consensus upside fast.
Risks: NBA approval and deal completion are not assured. The team estimates are not transaction bids. Lower attendance, weaker playoff performance, spin-off tax costs or governance concerns could keep MSGS below private-market benchmarks.
The near-term test starts at the open. Investors must decide whether stronger earnings and the Lakers benchmark justify closing more of the discount. The proposed October separation provides the next dated catalyst.



